Paper28041832
Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors.
Cui P and 5 others. Bioorg Med Chem Lett, 2017. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors. Papers, record 28041832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28041832
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Triphosphatases | Major topic |
| Anti-Bacterial Agents | Major topic |
| Bacterial Proteins | Major topic |
| Drug Design | Major topic |
| Enzyme Inhibitors | Major topic |
| SEC Translocation Channels | Major topic |
| Thiouracil | Major topic |
| Bacillus amyloliquefaciens | |
| Bacillus subtilis | |
| Binding Sites | |
| Microbial Sensitivity Tests | |
| Molecular Docking Simulation | |
| Protein Structure, Tertiary | |
| SecA Proteins | |
| Staphylococcus aureus |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42707565 | Synthesis, structure and computational study of N-acetyl-N'-(4-chloro-phen-yl)-thio-urea. | Acta Crystallogr E Crystallogr Commun | 2026 | https://conductscience.org/library/papers/42707565 | PubMed |
| 38900333 | Towards new bioactive fluorine-containing 1,3,4-oxadiazole-amide derivatives: synthesis, antibacterial activity, molecular docking and molecular dynamics simulation study. | Mol Divers | 2025 | https://conductscience.org/library/papers/38900333 | PubMed |
| 37237710 | New N-acyl Thiourea Derivatives: Synthesis, Standardized Quantification Method and In Vitro Evaluation of Potential Biological Activities. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37237710 | PubMed |
| 37049981 | Evaluation of Antibacterial Activity of Thiourea Derivative TD4 against Methicillin-Resistant Staphylococcus aureus via Destroying the NAD+/NADH Homeostasis. | Molecules | 2023 | https://conductscience.org/library/papers/37049981 | PubMed |
| 36985680 | Investigation of Newly Synthesized Bis-Acyl-Thiourea Derivatives of 4-Nitrobenzene-1,2-Diamine for Their DNA Binding, Urease Inhibition, and Anti-Brain-Tumor Activities. | Molecules | 2023 | https://conductscience.org/library/papers/36985680 | PubMed |
| 36838913 | Novel 2-Thiouracil-5-Sulfonamide Derivatives: Design, Synthesis, Molecular Docking, and Biological Evaluation as Antioxidants with 15-LOX Inhibition. | Molecules | 2023 | https://conductscience.org/library/papers/36838913 | PubMed |
| 36232944 | Analysis of 1-Aroyl-3-[3-chloro-2-methylphenyl] Thiourea Hybrids as Potent Urease Inhibitors: Synthesis, Biochemical Evaluation and Computational Approach. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232944 | PubMed |
| 34841164 | Single-Crystal Investigation, Hirshfeld Surface Analysis, and DFT Study of Third-Order NLO Properties of Unsymmetrical Acyl Thiourea Derivatives. | ACS Omega | 2021 | https://conductscience.org/library/papers/34841164 | PubMed |
| 33914211 | Synthesis, antifungal activity and 3D-QSAR study of novel acyl thiourea compounds containing gem-dimethylcyclopropane ring. | Mol Divers | 2022 | https://conductscience.org/library/papers/33914211 | PubMed |
| 32831951 | Synthesis of 3(2)-phosphonylated thiazolo[3,2-a]oxopyrimidines. | Beilstein J Org Chem | 2020 | https://conductscience.org/library/papers/32831951 | PubMed |
| 32100245 | Synthesis, characterization, antimicrobial, antioxidant and computational evaluation of N-acyl-morpholine-4-carbothioamides. | Mol Divers | 2021 | https://conductscience.org/library/papers/32100245 | PubMed |
| 30007321 | SecA inhibitors as potential antimicrobial agents: differential actions on SecA-only and SecA-SecYEG protein-conducting channels. | FEMS Microbiol Lett | 2018 | https://conductscience.org/library/papers/30007321 | PubMed |
| 29305616 | Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agents. | Cell Mol Life Sci | 2018 | https://conductscience.org/library/papers/29305616 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28041832
GET https://conductscience.org/api/papers/v1/28041832/authors